clarithromycin has been researched along with Disease Exacerbation in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 14 (38.89) | 29.6817 |
| 2010's | 20 (55.56) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Li, YD; Yu, BH | 1 |
| Becker, PS; Bensinger, W; Holmberg, LA | 1 |
| Ärnlöv, J; Carlsson, AC; Gluud, C; Hilden, J; Jakobsen, JC; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Larsson, A; Nowak, C; Ruge, T; Sajadieh, A; Winkel, P | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Dalman, RL | 1 |
| Akram, A; Chalmers, JD; Hill, AT; Schembri, S; Short, PM; Singanayagam, A; Taylor, J; Williamson, PA | 1 |
| Donaldson, GC; James, GD; Nazareth, I; Petersen, I; Wedzicha, JA | 1 |
| Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S | 1 |
| Agnoletti, AF; Drago, F; Parodi, A | 1 |
| Herath, SC; Poole, P | 1 |
| Akagawa, KS; Hirose, T; Kobayashi, K; Nagao, T; Nakayama, T; Ōmura, S; Oshima, M; Sugamata, R; Sugawara, A; Sunazuka, T; Suzuki, K; Yamamoto, K | 1 |
| Choi, YW; Jeon, SC; Kim, H; Kim, TH; Paik, SS; Park, DW; Park, SS; Shon, JW; Yoon, HJ | 1 |
| Akaike, H; Kato, T; Kawai, Y; Miyashita, N; Nakano, T; Okimoto, N; Ouchi, K; Tanaka, T; Teranishi, H | 1 |
| Yamaya, M | 1 |
| Avni, B; Barshay, Y; Benyamini, N; Ganzel, C; Gatt, ME; Goldschmidt, N; Gural, A; Lavie, D; Libster, D; Shaulov, A | 1 |
| Cho, J; Han, SK; Lee, CH; Park, J; Yim, JJ | 1 |
| Baconnet, B; Léophonte, P; Perronne, C; Zuck, P | 1 |
| Adam, J; Daya, H; Harris, RL; Heath, P; Modayil, P; Planche, T; Sharland, M | 1 |
| Randhawa, K; Smethurst, P; Soo Hoo, GW | 1 |
| Buzás, GM | 1 |
| Kafetzis, D; Konstantinou, GN; Koutsoubari, I; Makrinioti, H; Papadopoulos, NG; Papaevangelou, V; Xepapadaki, P | 1 |
| Akelma, AZ; Bozkurt, B; Mete, E | 1 |
| Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
| Coleman, M; Leonard, J; Lyons, L; Michaeli, J; Nahum, K; Niesvizky, R; Pearse, R; Pekle, K | 1 |
| Chan, FK; Ching, JY; Lau, JY; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF | 1 |
| Miravitlles, M; Torres, A | 1 |
| Eller, J; Ioanas, M; Linnhoff, A; Lode, H | 1 |
| Deng, D; Ke, Y; Shen, J; Zhang, JZ | 1 |
| Chang, J; de Wet, R; Fogarty, C; Mandell, L; Nusrat, R; Rangaraju, M | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Ochi, M; Okazaki, H; Oshitani, N; Sasaki, E; Shiba, M; Tominaga, K; Wada, T; Watanabe, T; Yamamori, K | 1 |
| Ergeshev, AE; Shmelev, EI; Shmeleva, NM; Sidorova, VP | 1 |
| Busman, TA; Gotfried, M; Norris, S; Notario, GF | 1 |
| Fox, JG; Ge, Z; Lee, CW; Rickman, B; Rogers, AB; Wang, TC | 1 |
| Bucher, HC; Craig, BA; Gafni, A; Pfluger, D; Sendi, PP | 1 |
| Hawkshaw, M; Sataloff, RT; Spiegel, JR | 1 |
| Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M | 1 |
4 review(s) available for clarithromycin and Disease Exacerbation
| Article | Year |
|---|---|
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic | 2013 |
[Effects of mucolytic agents and macrolides in the treatment of COPD].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Erythromycin; Expectorants; Goblet Cells; Humans; Hyperplasia; Macrolides; Mucins; Mucociliary Clearance; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Treatment Outcome | 2016 |
[Helicobacter pylori -- 2010].
Topics: Age Factors; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carbonic Anhydrases; Clarithromycin; Disease Progression; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; History, 19th Century; History, 20th Century; Humans; Peptic Ulcer; Prevalence; Recurrence; Remission, Spontaneous; Urease | 2010 |
9 trial(s) available for clarithromycin and Disease Exacerbation
| Article | Year |
|---|---|
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial S
Topics: Aged; Anti-Bacterial Agents; Biomarkers; Cause of Death; Clarithromycin; Coronary Disease; Denmark; Disease Progression; Female; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation | 2018 |
Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis.
Topics: Aged; Bronchiolitis; Clarithromycin; Disease Progression; Female; Humans; Macrolides; Male; Pneumonia, Aspiration | 2016 |
Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study.
Topics: Acute Disease; Anti-Asthmatic Agents; Anti-Bacterial Agents; Asthma; Child; Clarithromycin; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Respiratory Function Tests; Severity of Illness Index; Treatment Outcome | 2012 |
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metaplasia; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Risk Factors; Stomach Neoplasms | 2004 |
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome | 2004 |
Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
Topics: Acute Disease; Adult; Aged; Bronchitis; Chronic Disease; Clarithromycin; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Health Care Rationing; Humans; Ketolides; Male; Middle Aged; Single-Blind Method; Smoking; Vital Capacity | 2005 |
[Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Anti-Bacterial Agents; Clarithromycin; Disease Progression; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2006 |
Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bronchitis; Clarithromycin; Delayed-Action Preparations; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ketolides; Male; Middle Aged; Research Design; Severity of Illness Index; Sputum; Treatment Outcome | 2007 |
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
Topics: Aged; Biomarkers; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Combined Modality Therapy; Disease Progression; Female; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Protein Synthesis Inhibitors; Survival Analysis; Treatment Outcome; Weight Gain | 2001 |
23 other study(ies) available for clarithromycin and Disease Exacerbation
| Article | Year |
|---|---|
A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Coronary Disease; Disease Progression; Helicobacter pylori; Humans; Peptic Ulcer | 2022 |
Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Combined Modality Therapy; Consolidation Chemotherapy; Dexamethasone; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Peripheral Nervous System Diseases; Thalidomide; Transplantation, Autologous; Treatment Outcome | 2017 |
Invited commentary.
Topics: Administration, Oral; Aortic Aneurysm; Clarithromycin; Disease Progression; Humans | 2018 |
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Topics: Acute Coronary Syndrome; Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Disease Progression; Female; Follow-Up Studies; Guideline Adherence; Hospitalization; Humans; Male; Middle Aged; Pneumonia; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; United Kingdom | 2013 |
Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Disease Progression; Doxycycline; Erythromycin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Oxytetracycline; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sex Factors; United Kingdom | 2013 |
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed | 2013 |
Acute autoimmune thrombocytopenia and worsening of dermatomyositis after administration of clarithromycin.
Topics: Acute Disease; Clarithromycin; Dermatomyositis; Disease Progression; Female; Humans; Middle Aged; Purpura, Thrombocytopenic, Idiopathic | 2013 |
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate | 2014 |
Near fatal desquamative interstitial pneumonia with bilateral recurrent tension pneumothorax.
Topics: Adult; Biopsy, Needle; Clarithromycin; Combined Modality Therapy; Critical Illness; Disease Progression; Follow-Up Studies; Genetic Diseases, Inborn; Humans; Lung Diseases, Interstitial; Male; Multidetector Computed Tomography; Pneumothorax; Prednisolone; Rare Diseases; Recurrence; Risk Assessment; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2015 |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.
Topics: Adult; Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Disease Progression; Fatigue; Female; Humans; Immunoglobulin Light Chains; Immunoglobulin Light-chain Amyloidosis; Infections; Male; Middle Aged; Multiple Myeloma; Protein Synthesis Inhibitors; Recurrence; Salvage Therapy; Treatment Outcome | 2017 |
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Progression; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Risk Factors; Sputum; Treatment Outcome | 2017 |
[Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Child; Clarithromycin; Delayed-Action Preparations; Disease Progression; Drug Tolerance; Female; France; Humans; Middle Aged; Physicians, Family; Pulmonary Disease, Chronic Obstructive; Rural Population; Smoking; Urban Population | 2008 |
Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary?
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Disease Progression; Face; Humans; Infant; Lymph Nodes; Magnetic Resonance Imaging; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Treatment Outcome; Tuberculosis, Lymph Node | 2009 |
Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
Topics: Antitubercular Agents; Clarithromycin; Delayed Diagnosis; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2010 |
Clarithromycin in treatment of acute asthma exacerbations: principles of appropriate antibiotic use.
Topics: Anti-Bacterial Agents; Asthma; Clarithromycin; Disease Progression; Female; Humans; Male | 2012 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |
BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Disease Progression; Female; Humans; Immunoglobulins; Male; Middle Aged; Multiple Myeloma; Thalidomide; Time Factors; Treatment Outcome; Waldenstrom Macroglobulinemia | 2002 |
Antibiotics in exacerbations of COPD: lessons from the past.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2004 |
Formation of A2143G mutation of 23S rRNA in progression of clarithromycin resistance in Helicobacter pylori 26695.
Topics: Anti-Bacterial Agents; Clarithromycin; Disease Progression; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Mutation; RNA, Ribosomal, 23S | 2005 |
Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin.
Topics: Aged; Clarithromycin; Disease Progression; Duodenal Neoplasms; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell, Marginal Zone; Protein Synthesis Inhibitors | 2006 |
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithromycin; Disease Progression; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lithostathine; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Omeprazole; Precancerous Conditions; Stomach Neoplasms; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2008 |
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Computer Simulation; Disease Progression; Economics, Pharmaceutical; HIV Infections; Humans; Markov Chains; Mycobacterium avium-intracellulare Infection; Probability; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Factors; Switzerland | 1999 |
Prolonged ulcerative laryngitis.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Disease Progression; Female; Hoarseness; Humans; Laryngeal Diseases; Prednisone; Ulcer; Vocal Cords | 2000 |